Karyopharm Therapeutics Inc (KPTI) — Financial Flexibility Index
Karyopharm Therapeutics Inc (KPTI) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of $-11.83 Million (operating CF $-11.83 Million minus capex $0.00) represents 0% of total liabilities ($401.34 Million). Also explore KPTI net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Karyopharm Therapeutics Inc Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Karyopharm Therapeutics Inc across 15 annual periods. Check Karyopharm Therapeutics Inc (KPTI) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Karyopharm Therapeutics Inc (2011–2025)
Year-by-year free cash flow to debt coverage for Karyopharm Therapeutics Inc. For the full company profile including market capitalisation, see market value of Karyopharm Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.19x | $-75.37 Million | $-75.37 Million | $401.34 Million | ▲ +48.3% |
| 2024 | -0.36x | $-127.34 Million | $-127.49 Million | $350.44 Million | ▼ -47.6% |
| 2023 | -0.25x | $-92.72 Million | $-92.72 Million | $376.64 Million | ▲ +38.3% |
| 2022 | -0.40x | $-149.44 Million | $-149.55 Million | $374.83 Million | ▼ -51.4% |
| 2021 | -0.26x | $-101.40 Million | $-107.12 Million | $384.98 Million | ▲ +56.8% |
| 2020 | -0.61x | $-160.09 Million | $-160.23 Million | $262.50 Million | ▲ +21.6% |
| 2019 | -0.78x | $-190.62 Million | $-190.82 Million | $245.19 Million | ▲ +21.6% |
| 2018 | -0.99x | $-156.75 Million | $-159.12 Million | $158.02 Million | ▲ +31.5% |
| 2017 | -1.45x | $-73.66 Million | $-73.72 Million | $50.83 Million | ▲ +68.8% |
| 2016 | -4.65x | $-84.32 Million | $-84.39 Million | $18.14 Million | ▲ +14.3% |
| 2015 | -5.42x | $-92.61 Million | $-94.03 Million | $17.08 Million | ▼ -51.1% |
| 2014 | -3.59x | $-48.61 Million | $-51.45 Million | $13.54 Million | ▲ +60.9% |
| 2013 | -9.18x | $-30.23 Million | $-30.29 Million | $3.29 Million | ▼ -1642.0% |
| 2012 | -0.53x | $-15.39 Million | $-15.51 Million | $29.19 Million | ▼ -28.2% |
| 2011 | -0.41x | $-8.17 Million | $-8.55 Million | $19.88 Million | — |